Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis
This study found increased serum VEGF in secretory phases and TNF-α in all phases in endometriosis patients, with a positive correlation between CRP and VEGF.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study followed 25 women with endometriosis (ASRM stage III–IV) and 13 controls across one menstrual cycle, measuring serum VEGF, TNF-α, and CRP by ELISA in early/late proliferative and early/late secretory phases. The authors reported increased serum VEGF during secretory phases and increased TNF-α across all cycle phases in the endometriosis group. They found a positive correlation between CRP and VEGF in endometriosis patients, but not in controls. A key limitation explicitly reflected by the design is the small sample size and the single-cycle follow-up, which constrains generalizability. This paper is centrally about endometriosis — it quantifies cyclic changes in VEGF and TNF-α and their association with CRP in patients with endometriosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Angiongenesis: a new theory for endometriosis via openalex
- Changes in immunologic variables (TNF-a, sCD8 and sCD4) during danazol treatment in patients with endometriosis. via openalex
- Endometriosis 1991: a discussion document via openalex
- Endometriosis: abnormal endometrium and dysfunctional immune response via openalex
- Increased Leptin Levels in Serum and Peritoneal Fluid of Patients with Pelvic Endometriosis via openalex
- Increased Leptin Levels in Serum and Peritoneal Fluid of Patients with Pelvic Endometriosis1 via openalex
- Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex
- Pathogenesis of endometriosis via openalex
- Pathogenesis of Endometriosis via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of cytokines in endometriosis via openalex
- Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours via openalex
- Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines via openalex
- Serum Concentrations of Insulin‐like Growth Factor‐1, Soluble Tumor Necrosis Factor Receptor‐1 and Angiogenin in Endometriosis Patients via openalex
- The epidemiology of endometriosis via openalex
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production via openalex
- W2147624141 via openalex
- W2042642675 via openalex
- W2140246703 via openalex
- W2010744188 via openalex
- W2022041162 via openalex
- W2004348481 via openalex
- W2327470041 via openalex
- W2401134385 via openalex
- W2607412715 via openalex
Cited by (50)
- Inflammatory Cytokine Signatures Are Associated With Disease Burden and Comorbidity of Episodic Migraine and Endometriosis 2025
- Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies 2025
- Endometriosis in Adolescence: A Narrative Review of the Psychological and Clinical Implications 2025
- Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment 2025
- Endometriosis: A Comprehensive and Concise Review of Potential Biomarkers and Treatment Therapies 2024
- Novel Diagnostic Biomarker BST2 Identified by Integrated Transcriptomics Promotes the Development of Endometriosis via the TNF-α/NF-κB Signaling Pathway 2024
- Role of TNF superfamily members lymphotoxin-α, sCD40L, and TNF-α in endometriosis-related infertility 2024
- How Do Microorganisms Influence the Development of Endometriosis? Participation of Genital, Intestinal and Oral Microbiota in Metabolic Regulation and Immunopathogenesis of Endometriosis 2023
- Fraxetin reduces endometriotic lesions through activation of ER stress, induction of mitochondria-mediated apoptosis, and generation of ROS 2023
- Predictive Value of Serum Vascular Endothelial Growth Factor Level for Postoperative Endometriosis Recurrence in Patients with Ovarian Endometriosis 2023
- Targeting NGF but not VEGF or BDNF signaling reduces endometriosis-associated pain in mice 2023
- Molecular Mechanisms of Endometriosis Revealed Using Omics Data 2023
- How to Improve Non-Invasive Diagnosis of Endometriosis with Advanced Statistical Methods 2023
- The link between inflammation and hemostasis in endometriosis: a call for research 2023
- Effects of polyamine synthesis enzymes on angiogenesis and apoptosis during endometriosis 2022
- Endometriosis through an immunological lens: a pathophysiology based in immune dysregulation 2022
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- Endometriosis Research: From Bench to Bedside 2022
- The role of some inflammatory markers, cytokins and tumor markers in diagnosis of endometriosis 2022
- The Role of the Microenvironment in Endometriosis: Parallels and Distinctions to Cancer 2022
- Diagnostic use of CA 125 values measured on the 2nd and 14th days of the menstrual cycle in endometriosis 2022
- Effect of early inflammatory reaction on ovarian reserve after laparoscopic cystectomy for ovarian endometriomas 2022
- Serum Level of Ligand Programmed Death-1 in Endometriosis 2022
- The Phytochemical Profile and Biological Activity of Malva neglecta Wallr. in Surgically Induced Endometriosis Model in Rats 2022
- Analysis of Changes in Serum Levels and Gene Expression Profiles of Novel Adipocytokines (Omentin, Vaspin, Irisin and Visfatin) and Their Correlation with Serum C-reactive Protein Levels in Women Diagnosed with Endometriosis 2021
- Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis 2021
- The immune system and endometriosis 2021
- Molecular biomarkers of endometriosis 2021
- Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate 2021
- The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis 2021
- Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives 2020
- Is there a Relationship Between Vitamin D and Endometriosis? An Overview of the Literature 2019
- Effects of clarithromycin on inflammatory markers and clinical manifestations in postsurgical follow-up of patients with endometriosis: a double-blinded randomized placebo-controlled clinical trial 2019
- Noninvasive markers of endometriosis and their dynamics during hormone therapy 2018
- Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis 2018
- Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies 2017
- Peripheral Blood Biomarkers for Endometriosis 2017
- A Prospective Study of Inflammatory Markers and Risk of Endometriosis 2017
- Performance of Circulating Placental Growth Factor as A Screening Marker for Diagnosis of Ovarian Endometriosis: A Pilot Study. 2016
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Identifying biomarkers for non-invasive diagnosis of endometriosis 2016
- Preoperative assessment and diagnosis of endometriosis 2015
- 1,25‐Dihydroxy Vitamin D3 Modulates Endometriosis‐Related Features of Human Endometriotic Stromal Cells 2015
- Serum Markers for the Noninvasive Diagnosis of Endometriosis 2015
- The diagnosis of endometriosis with the help of mass spectrometry (a review) 2015
- Serum YKL-40 levels are altered in endometriosis 2014
- Biomarkers of Endometriosis 2014
- Atorvastatin exerts anti-nociceptive activity and decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in a rat endometriosis model 2014
- Investigation of serum proteome alterations in human endometriosis 2014
- Copeptin is associated with the severity of endometriosis 2014
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:29.922408+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00